• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy & Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Press Releases
    • Media Requests
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

ADD/ADHD

Focusing on ADD/ADHD during Pregnancy and Breastfeeding

Disclaimer: This page houses important information and resources pertaining to ADD/ADHD during pregnancy and while breastfeeding, including links to our evidence-based Fact Sheets. However, the resources here should not replace the care and advice of a medical professional.

ADD/ADHD is a mental health condition in which people may have trouble paying attention and focusing, controlling impulsive behaviors (act without thinking about what the result will be), or they may be hyperactive (overly active and restless). Although ADD/ADHD is more often diagnosed in childhood, it is not just a childhood disorder and can continue through adulthood. People with ADD/ADHD may also have other mental health conditions, such as depression or anxiety.

“Effective treatment for ADHD in adult women may involve a multimodal approach that includes medication, psychotherapy, stress management, as well as ADHD coaching and/or professional organizing.”

— Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)

For many of the medications used to treat ADD/ADHD, there is not enough known to determine their safety or risk if used during pregnancy or while breastfeeding. Some people with mild to moderate symptoms of ADD/ADHD may be able to stop taking their medications when they are expecting or nursing, but other people may need to continue treatment with a stimulant to function every day. It is important to talk to your healthcare provider about options for managing ADD/ADHD when planning to get pregnant or during pregnancy and breastfeeding. 

Reference: Faraone et al. Psychol Med. 2006 Feb;36(2):159-65.

Please see our library of resources below on ADD/ADHD exposure during pregnancy and breastfeeding.

Related Fact Sheets

  • Atomoxetine (Strattera®)
  • Clonidine
  • Dextroamphetamine
  • Guanfacine (Intuniv®, Tenex®)
  • Methamphetamine
  • Methylphenidate (Ritalin®, Concerta®)
  • Nortriptyline
  • Venlafaxine (Effexor®)

Related Baby Blogs

  • ADD/ADHD: Focusing on What’s Best for Mom and Baby during Pregnancy

External Resources

  • Center for Disease Control: Attention-Deficit / Hyperactivity Disorder (ADHD)
  • Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD): ADHD Medication and Pregnancy
  • National Institute of Mental Health: Attention-Deficit / Hyperactivity Disorder

Partners

  • Patient Education Genius
  • PatientsLikeMe
  • Society for Maternal-Fetal Medicine
  • Society for Birth Defects Research & Prevention
  • The Mighty

Stay in Touch

Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.

Sign Up

Join a Study

Pregnant moms deserve better information about medication safety – and you can help by participating in a study.

JOin

Ask Our Experts

Call, text, chat, or email for a free personalized risk assessment on exposures in pregnancy and breastfeeding.

Contact

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whopping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2021 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^